| scholarly article | Q13442814 |
| P2093 | author name string | Malcolm D Yates | |
| Francis A Drobniewski | |||
| Annika Krüüner | |||
| P2860 | cites work | Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. | Q54011836 |
| The design of sensitivity tests on tubercle bacilli | Q79068094 | ||
| Is second-line anti-tuberculosis drug susceptibility testing reliable? | Q80802333 | ||
| Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis; results of simultaneous sensitivity tests in liquid and on solid media | Q33600955 | ||
| Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis | Q33946393 | ||
| Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. | Q33962909 | ||
| Spread of drug-resistant pulmonary tuberculosis in Estonia | Q33973479 | ||
| Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis | Q33974320 | ||
| Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia | Q34198320 | ||
| Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis | Q34823019 | ||
| The global situation of MDR-TB. | Q35131998 | ||
| Fluoroquinolones, tuberculosis, and resistance | Q35167433 | ||
| Criteria for the control of drug-resistant tuberculosis | Q35178438 | ||
| Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia | Q35537453 | ||
| Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method | Q36600112 | ||
| Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes | Q36719383 | ||
| Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family. | Q37334510 | ||
| Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis | Q39665225 | ||
| Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis | Q39735527 | ||
| Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion | Q39746698 | ||
| Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin | Q40279724 | ||
| Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis | Q40572948 | ||
| MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE | Q42081575 | ||
| Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems. | Q43997528 | ||
| PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. | Q44463433 | ||
| Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study | Q44742886 | ||
| Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy | Q45098230 | ||
| Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy | Q45235311 | ||
| High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002. | Q45283455 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| antimicrobial resistance | Q63391344 | ||
| P304 | page(s) | 811-818 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis | |
| P478 | volume | 44 |
| Q55227253 | A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis. |
| Q36087053 | Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk. |
| Q28476208 | An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia |
| Q42229494 | Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. |
| Q35599028 | Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis |
| Q35810687 | Clinical and epidemiological profiles of individuals with drug-resistant tuberculosis |
| Q35959145 | Clinical and laboratory observation of Bacillus Calmette-Guérin infections |
| Q34046259 | Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates |
| Q34520274 | Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa |
| Q35181330 | Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay |
| Q36794791 | Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis |
| Q35943005 | Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study. |
| Q28551469 | Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country |
| Q30414792 | Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory |
| Q98467200 | Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: Impact on bedside clinical decision making |
| Q39872573 | Drug-susceptibility testing in TB: current status and future prospects |
| Q99635652 | Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution |
| Q36773017 | Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis |
| Q34046282 | Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis |
| Q35139804 | Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings |
| Q37611572 | Evolution and transmission of drug-resistant tuberculosis in a Russian population |
| Q37291363 | Extensively drug-resistant tuberculosis: new strains, new challenges |
| Q28534345 | First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries |
| Q37187468 | Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance |
| Q38386834 | Fluoroquinolones for the treatment of tuberculosis in children. |
| Q33645712 | Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1. |
| Q36290565 | Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. |
| Q36864780 | High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China |
| Q35944061 | High time to use rapid tests to detect multidrug resistance in sputum smear-negative tuberculosis in Belarus |
| Q33798527 | In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis |
| Q30300560 | Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes |
| Q36290285 | Macrocolonies (Granules) Formation as a Cause of False-Negative Results in the MGIT 960 System: Cause Analysis and Correlation with Mycobacterial Species |
| Q42715629 | Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement |
| Q35864738 | Microevolution of extensively drug-resistant tuberculosis in Russia |
| Q47139155 | Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China |
| Q42577091 | Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States |
| Q47173840 | Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades |
| Q42613641 | Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex |
| Q42432121 | Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis |
| Q36509397 | Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors |
| Q37000097 | Multidrug-resistant tuberculous meningitis |
| Q24170218 | Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis |
| Q33417860 | Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation |
| Q39079472 | Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system |
| Q34757821 | Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis |
| Q39990545 | Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation |
| Q35757756 | Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples |
| Q39218265 | Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system |
| Q34259008 | Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960. |
| Q41113390 | Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries |
| Q36917933 | Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex |
| Q30278816 | Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs |
| Q37532923 | Sub-optimal Specificity of Modified Ziehl-Neelsen Staining for Quick Identification of Tuberculous Meningitis |
| Q28478528 | Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia |
| Q35577316 | Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study |
| Q42111827 | Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics |
| Q34304465 | Susceptibility testing to second-line drugs and ethambutol by GenoType MTBDRsl and Bactec MGIT 960 comparing with agar proportion method |
| Q30455525 | The future of molecular diagnostics for drug-resistant tuberculosis |
| Q24656698 | Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro |
| Q34201423 | Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis |
| Q30409793 | Use of mycobacteriophage quantitative PCR on MGIT broths for a rapid tuberculosis antibiogram |
| Q37302822 | Worldwide emergence of extensively drug-resistant tuberculosis |
| Q46168942 | gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis |
Search more.